Indication
SGLT-2 Inhibitors
1 clinical trial
2 products
Clinical trial
Impact of Additional Treatment With Empagliflozin or Semaglutide on Endothelial Function and Other Clinical Parameters and Biomarkers in T1DM PatientsStatus: Completed, Estimated PCD: 2022-03-10
Product
SemaglutideProduct
Empagliflozin